Table 2 Summary of immunohistochemical and molecular findings in cohort of patients with hybrid schwannoma–perineurioma.
From: Hybrid schwannoma–perineurioma frequently harbors VGLL3 rearrangement
Case | Immunohistochemistry | RNA-seq | FISH | ||||||
|---|---|---|---|---|---|---|---|---|---|
S100 | SOX10 | CD34 | EMA | Claudin-1 | GLUT-1 | H3K27me3 | |||
Index | D+ | D+ | D+ | M+ | M+ | M+ | Intact | CHD7-VGLL3 | +/+ |
2 | D+ | D+ | M+ | M+ | N/A | N/A | Intact | CHD7-VGLL3 | N/A |
3 | D+ | D+ | D+ | M+ | M+ | M+ | N/A | CHD7-VGLL3 | N/A |
4 | D+ | N/A | M+ | M+ | Multifocal | N/A | N/A | CHD7-VGLL3 | N/A |
5 | D+ | N/A | M+ | D+ | N/A | N/A | N/A | CHD7-VGLL3 | N/A |
6 | D+ | N/A | D+ | D+ | N/A | N/A | N/A | CHD7-VGLL3 | N/A |
7 | M+ | N/A | N/A | M+ | N/A | N/A | N/A | CHD7-VGLL3 | N/A |
8 | D+ | D+ | N/A | N/A | N/A | N/A | N/A | CHD7-VGLL3* | +/+ |
9 | D+ | D+ | M+ | N/A | N/A | N/A | Intact | CHD7-VGLL3* | +/+ |
10 | D+ | D+ | D+ | M+ | N/A | M+ | Intact | CHD7-VGLL3* | +/+ |
11 | D+ | D+ | D+ | F+ | D+ | F+ | N/A | CHD9-VGLL3 | N/A |
12 | M+ | N/A | D+ | D+ | N/A | N/A | N/A | CHD9-VGLL3 | N/A |
13 | M+ | M+ | D+ | M+ | N/A | N/A | Intact | MAMLD1-VGLL3 | N/A |
14 | D+ | D+ | N/A | – | N/A | N/A | N/A | MAMLD1-VGLL3* | N/A/+ |
15 | M+ | M+ | M+ | M+ | M+ | M+ | N/A | DST-BRAF | +/+ |
16 | D+ | D+ | – | M+ | M+ | – | N/A | SQSTM1-CDX1 | N/A |
17 | M+ | N/A | M+ | M+ | M+ | N/A | N/A | Negative | −/− |
18 | D+ | N/A | N/A | M+ | M+ | N/A | N/A | Negative | −/− |